Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Survival. Found 22 abstracts

no pagination
Moten AS, Zhao H, Howell K, Nadler A, Reddy SS, von Mehren M, Movva S, Farma JM. Soft tissue sarcoma of the extremity: Characterizing symptom duration and outcomes. Surgical oncology. 2019 Jun;29:190-5.
Reyngold M, Winter KA, Regine WF, Abrams RA, Safran H, Hoffman JP, Mowat RB, Hayes JP, Kessel IL, DiPetrillo T, Narayan S, Chen Y, Ben-Josef E, Delouya G, Suh JH, Meyer J, Haddock MG, Feldman M, Gaur R, Yost K, Peterson RA, Sherr DL, Moughan J, Crane CH. Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704. The oncologist. 2019 Dec 16;.
Borghaei H, Yim YM, Guerin A, Pivneva I, Shi S, Gandhi M, Ionescu-Ittu R. Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy. Lung Cancer. 2018 May;119:112-9.
Bryan MS, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone K, John EM, Gammon MD, Daly M, Terry MB, Buys SS, Huo DZ, Olopade O, Genkinger JM, Jasmine F, Kibriya MG, Chen L, Ahsan H. Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. Breast Cancer Res Treat. 2017 Aug;164(3):707-17.   PMCID: PMC5510603
Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P. Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Feb;23(2):269-77.   PMCID: PMC5346183
Costa LJ, Maddocks K, Epperla N, Reddy NM, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn MJ, Chavez JC, Calzada O, Lansigan F, Nasheed H, Barta SK, Zhou Z, Jaglal M, Chhabra S, Hernandez-Ilizaliturri F, Xavier AC, Mehta A, Peker D, Forero-Torres A, Al-Mansour Z, Evens AM, Cohen JB, Flowers CR, Fenske TS, Hamadani M. Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies. American journal of hematology. 2017 Feb;92(2):161-70.   PMCID: PMC5549936
Necchi A, Pond GR, Raggi D, Ottenhof SR, Djajadiningrat RS, Horenblas S, Khoo V, Hakenberg OW, Draeger D, Protzel C, Heidenreich A, Haidl F, Eigl BJ, Nappi L, Matsumoto K, Vaishampayan U, Woods ME, Salvioni R, Nicolai N, Catanzaro M, Giannatempo P, Geynisman DM, Preto M, Xylinas E, Milowsky MI, De Placido S, Di Lorenzo G, Sonpavde G. Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis. Clin Genitourin Cancer. 2017 Oct;15(5):548-555 e3.
Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone K, John EM, Gammon MD, Daly M, Terry MB, Buys SS, Huo D, Olopade O, Genkinger JM, Jasmine F, Kibriya MG, Chen L, Ahsan H. Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. Breast Cancer Res Treat. 2017 Aug;164(3):707-17.   PMCID: PMC5510603
Bayne CE, Williams SB, Cooperberg MR, Gleave ME, Graefen M, Montorsi F, Novara G, Smaldone MC, Sooriakumaran P, Wiklund PN, Chapin BF. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol. 2016 May 20;69(5):775-87.
Chan JK, Java JJ, Fuh K, Monk BJ, Kapp DS, Herzog T, Bell J, Young R. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. Gynecol Oncol. 2016 Dec;143(3):490-5.   PMCID: PMC5728987
Ledezma RA, Negron E, Paner GP, Rjepaj C, Lascano D, Haseebuddin M, Dangle P, Shalhav AL, Crist H, Raman JD, Joel DeCastro G, Harik L, Paroder M, Uzzo RG, Kutikov A, Eggener SE. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World journal of urology. 2016 May;34(5):687-93.
Mehrazin R, Uzzo RG, Kutikov A, Ruth K, Tomaszewski JJ, Dulaimi E, Ginzburg S, Abbosh PH, Ito T, Corcoran AT, Chen DY, Smaldone MC, Al-Saleem T. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations. 2015 Sep;33(9):388e19-388e25.   PMCID: 4289664
Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2014 Mar 15;120(6):840-7.   PMCID: Pmc3951722
Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON SCORE 8 TO 10 PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1949-56.   PMCID: PMC3827957
Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong YN, Carter B, Javid S, Edge S, Burstein H, Golshan M. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Research and Treatment. 2011 Sep;129(2):459-65.   PMCID: PMC3382105
Rose PG, Tian CQ, Bookman MA. Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 2010 May;117(2):324-9.   PMCID: NIH funded - needs PMCID
Horwitz EM. Does addition of 6 months' androgen suppression to radiotherapy prolong survival of men with prostate cancer?. Nature Clinical Practice Urology. 2005 Jan;2(1):16-7.
Manne SL, Ostroff JS, Winkel G, Fox K, Grana G, Miller E, Ross S, Frazier T, Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A, Morrow M, Chen JQ, Yager JD, Russo J, Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ, Devlin J, Sherman E, Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR, Murphy ME, Langer CJ, Mehta MP, Viterbo R, Greenberg RE, Al-Saleem T, Canutescu AA, Dunbrack RL, Serebriiskii IG, Fang R, Latypova E, Hopkins R, Vinson C, Joung JK, Golemis EA. Couple-focused group intervention for women with early stage breast cancer. . J Consult Clin Psychol. 2005 Sep 15;73(4):634-46.
Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol. 2003 Jul;21(13):2597-9.
Movsas B, Hudes RS, Schol J, Millenson M, Rosvold E, Nicolaou N, Litwin S, Wang H, Keenan E, Curran WJ, Langer CJ. Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report. Clinical lung cancer. 2001 Jan;3(2):125-32.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Survival

Survival Female Prognosis Adult Middle Aged Aged Male complications 80 and over Aged pathology chemotherapy Early onset breast cancer mortality Paclitaxel therapy Quality of Life Kidney Neoplasms etiology Gene-based tests drug therapy Whole-genome prediction Single nucleotide variants surgery Proportional Hazards Models Chemotherapy Kaplan-Meier Estimate methods Skat-o therapeutic use Carboplatin Adjuvant Chemotherapy Anticonvulsants Cystic Neoplasms-Mucinous-and Serous rt [Radiotherapy] Plasmids Attitude to Health Lymphopenia Proto-Oncogene Proteins c-raf Time Factors Drug Administration Schedule Base Sequence Disease control Organizational Policy Computer Simulation Symptom duration dt [Drug Therapy] analysis Combined Modality Therapy Radiation Dosage Biomarker Inflammatory disease Bacterial Proteins Myeloma Molecular Sequence Data Head and Neck Neoplasms Radiation Comparative Study psychology Escherichia coli stage-iii Renal Cell Carcinoma Sequence Alignment Relapse Costs Radiosurgery Cohort Studies dysphagia 0 (Plasmids) Software Risk Antineoplastic Agents intensity-modulated radiotherapy Intravenous Infusions Ovarian Neoplasms pegylated liposomal Amino Acid Sequence Homology 0 (Anticonvulsants) Progression-free Ovarian Epithelial Carcinoma Saccharomyces cerevisiae Prostate cancer Lymphoma Genes Mastectomy Lung Neoplasms phase-iii trial reconstruction metabolism Clear Cell Adenocarcinoma topotecan Second-line therapy Marital status Treatment Outcomes competing risk Adrenal Gland Neoplasms Endometrioid Carcinoma 0 (Proteins) Middle Age Disease Progression head and neck cancer Multivariate Analysis Cisplatin Adrenal Cortex Hormones prostate cancer Clinical Assessment Tools Recombinant Fusion Proteins Molecular Models Non-US Gov't Research Support Breast Neoplasms Lymphocyte count Local Neoplasm Recurrence Non-Hodgkin site phase-ii trial Seizures Preoperative chemotherapy Papillary RCC EC 27137 (Proto-Oncogene Proteins c-raf) Two-Hybrid System Techniques Granulocyte Colony-Stimulating Factor Aromatase Weight Loss ae [Adverse Effects] platinum-refractory ovarian User-Computer Interface defining biochemical failure Maintenance Androgen suppression Transplantation Hematopoietic Stem Cell Transplantation Systems Integration Renal cell carcinoma Prostatectomy Karnofsky Performance Status Papillary renal cell carcinoma Pain US Gov't Research Support-PHS Squamous cell carcinoma Palliative Care cell-lung-cancer DNA-Binding Proteins High grade Prospective Studies genetics Treatment Outcome Stage IV breast cancer myc ad [Administration and Dosage] peritoneal carcinoma doxorubicin
Last updated on Friday, January 03, 2020